device · product 1 of 1
Accula SARS-CoV-2 Test, REF: COV4100
- Recall number
- Z-1009-2022
- Initiated
- April 06, 2022
- Classification
- Class I
- Status
- Ongoing
- Recalling firm
- MESA BIOTECH, INC
- Quantity
- 6162
App-derived interpretation
SARS-CoV-2 Test has an increased potential for false positive results, which may lead to a delay in correct diagnosis and treatment.
Official device-enrichment evidence · Sourced
Material/Component Contamination
Inspect official wording and provenance
Reason for recall
SARS-CoV-2 Test has an increased potential for false positive results, which may lead to a delay in correct diagnosis and treatment.
Code information
UDI/DI: B540COV41000; P22006-026, P22010-021, P22024-023, P22024-030, P22026-006, P22026-012, P22026-016 , P22010-001, P22010-030, P22024-026, P22024-032, P22026-007, P22026-013, P22026-017 , P22010-017, P22010-032, P22024-027, P22026-002, P22026-008, P22026-014, P22026-019 , P22010-019, P22024-021, P22024-028, P22026-004, P22026-009, P22026-015, P22032-011
Distribution pattern
US Nationwide distribution in the states of CA, TX, MA, NY, FL, NC, NJ, GA, CO, HI, PA, WA, NY, VA, MD, KY, WI, IL, PR, ND, MI, TN, AZ, UT.